Although great emphasis has been put on IL-1β’s possible effects on the tumor microenvironment and in the induction of antitumor immune responses, opportunities for treating cancer by inflammasome manipulation may be emerging due to the recent discovery of the potential of pyroptosis in inducing immune-mediated rejection of tumors. The gene discussed is IL1B; the disease is cancer.